News

Nusano to Present Production Capabilities to European Radiopharmaceuticals Working Group

Proprietary ion source and beam technology capable of producing approximately 10 times the current global supply of Astatine-211WEST VALLEY CITY,…

2 years ago

Biora Therapeutics Appoints Dr. Ariella Kelman as Chief Medical Officer

SAN DIEGO, May 01, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic…

2 years ago

Casana Receives FDA Clearance for Heart Health Smart Toilet Seat

Casana obtained FDA clearance for measuring Heart Rate (HR) and Oxygen Saturation (SpO2)Sensors embedded in the toilet seat enable effortless…

2 years ago

Cassava Sciences Reports Q1 2023 Financial Results and Operating Updates

Over 1,244 Alzheimer’s patients now enrolled in Phase 3 studies of simufilam.Completion of patient enrollment for Phase 3 program still…

2 years ago

Day One Reports First Quarter 2023 Financial Results and Corporate Progress

FIREFLY-1 clinical abstract selected for oral presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting Leadership team…

2 years ago

Nanox.ARC Imaging System Receives FDA Clearance, Pioneering a New Era in Medical Imaging

Nanox.ARC Image of the Nanox ARC Nanox.ARC Image of the Nanox ARCNanox.ARC presents high powered digital X-ray tubes for 3D…

2 years ago

Neuronetics Announces Lisa Metzner-Rosas as SVP, Chief Marketing Officer

Strategic role strengthens NeuroStar® Advanced Therapy commercialization teamMALVERN, Pa., May 01, 2023 (GLOBE NEWSWIRE) --  Neuronetics, Inc. (NASDAQ: STIM), a…

2 years ago

New GIMOTI Patent Listed in FDA Orange Book

Broad Formulation Patent Expands Protection for GimotiSOLANA BEACH, Calif., May 01, 2023 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty…

2 years ago

Acer Therapeutics Announces OLPRUVA™ Commercial Launch Progressing Ahead of Schedule

Availability: OLPRUVA™ drug in channel now anticipated in mid-June 2023 Awareness: 70% of metabolic treatment providers surveyed by Acer at…

2 years ago